Clinical Trials on HER2 Amplified Breast Cancer in Russian Federation
Total 204 results
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityCompletedFemale | HER2-positive Breast CancerRussian Federation
-
N.N. Petrov National Medical Research Center of...RecruitingOligometastatic Disease | HER2-positive Metastatic Breast CancerRussian Federation
-
Blokhin's Russian Cancer Research CenterRussian Society of Clinical OncologyCompletedMetastatic Disease | HR+/HER2- Breast Cancer | Аdvanced DiseaseRussian Federation
-
OmicsWay Corp.Oncobox Ltd., Russia; Vitamed LLC, Russia; Republican Oncological Dispensary...Active, not recruitingHER2-positive Breast CancerUnited States, Russian Federation
-
Novartis PharmaceuticalsRecruiting
-
Eli Lilly and CompanyCompletedBreast Cancer | Neoplasm MetastasisRussian Federation
-
Russian Academy of Medical SciencesCompletedEarly Triple Negative Breast CancerRussian Federation
-
Tomsk National Research Medical Center of the Russian...RecruitingPrimary Breast CancerRussian Federation
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityCompletedBreast Cancer FemaleRussian Federation
-
Tomsk National Research Medical Center of the Russian...Enrolling by invitationBreast Cancer FemaleRussian Federation
-
Tomsk National Research Medical Center of the Russian...CompletedBreast Cancer FemaleRussian Federation
-
Tomsk National Research Medical Center of the Russian...Uppsala University; Institute of Bioorganic Chemistry, Russian Academy of SciencesCompletedPrimary Breast CancerRussian Federation
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityCompletedBreast Cancer FemaleRussian Federation
-
Russian Academy of Medical SciencesCompletedInduction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast CancerTriple Negative Breast CancerRussian Federation
-
Blokhin's Russian Cancer Research CenterRecruitingBreast Cancer Stage IVRussian Federation
-
Center of Personalized Medicine, PirogovaI.M. Sechenov First Moscow State Medical University; Center for New Medical...UnknownBreast Cancer-specific SurvivalRussian Federation
-
Prestige Biopharma LimitedCompletedHER2 Positive Breast CancerSpain, Malaysia, Estonia, Hungary, Thailand, Belarus, Bulgaria, France, Georgia, Italy, Poland, Russian Federation, Ukraine
-
Tatarstan Cancer CenterUnknownHereditary Breast CancerRussian Federation
-
Tomsk National Research Medical Center of the Russian...Uppsala University; KTH Royal Institute of TechnologyCompleted
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityCompletedBreast Cancer | FemaleRussian Federation
-
KARANAHANRecruitingStage IV Breast CancerRussian Federation
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityCompletedProstate Cancer | Breast Cancer FemaleRussian Federation
-
Blokhin's Russian Cancer Research CenterRecruitingBreast Cancer | Neoadjuvant Endocrine TherapyRussian Federation
-
N.N. Petrov National Medical Research Center of...UnknownBreast CancerRussian Federation
-
BiocadCompletedBreast CancerRussian Federation
-
N.N. Petrov National Medical Research Center of...UnknownBreast CancerRussian Federation
-
N.N. Petrov National Medical Research Center of...RecruitingRefusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response (pCR) Using VAB and SLNBRussian Federation
-
Merrimack PharmaceuticalsCompletedHer2 Negative Breast Cancer PatientsUnited States, Spain, Canada, Germany, Russian Federation
-
Eli Lilly and CompanyCompleted
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityRecruitingBreast Cancer | Prostate CancerRussian Federation
-
Moscow Clinical Scientific CenterRecruitingBreast Cancer | Solid Tumor | Gastrointestinal Cancer | Gynecological Malignancies | High-Risk Cancer | MyelosuppressionRussian Federation
-
Alpha Tau Medical LTD.TerminatedMetastatic Breast Cancer | Breast Carcinoma | Invasive Breast Cancer | Distant Metastases.PathologyRussian Federation
-
BiocadActive, not recruiting
-
I.M. Sechenov First Moscow State Medical UniversityRecruitingBreast Cancer | Postsurgical Acquired Absence of OrganRussian Federation
-
BiocadRecruitingBreast CancerRussian Federation
-
AstraZenecaDaiichi Sankyo Co., Ltd.RecruitingPart 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer | Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerCanada, Korea, Republic of, Taiwan, United States, Italy, United Kingdom, Thailand, Russian Federation, India, Belgium, Australia, Poland, Spain, Japan, Brazil, Czechia, Netherlands
-
Moscow Clinical Scientific CenterNegovsky Reanimatology Research InstituteRecruiting
-
Moscow Clinical Scientific CenterRecruitingBreast Cancer | Pancreas CancerRussian Federation
-
Meabco A/SMeddoc; Norwegian University of Life SciencesCompletedMetastatic Breast Cancer | Stage IV Breast CancerThailand, Russian Federation
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Early-stage Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
Achieve Life SciencesCompletedBreast CancerRussian Federation
-
BiocadCompletedHuman Epithelial Receptor (HER)-2 Positive Breast CancerUkraine, Russian Federation, Belarus, India
-
Meabco A/SMeddoc; Norwegian University of Life SciencesCompletedMetastatic Breast Cancer | Stage IV Breast CancerThailand, Russian Federation
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
AstraZenecaActive, not recruitingAdvanced ER-Positive HER2-Negative Breast CancerUnited States, Italy, Spain, Belgium, Poland, Canada, Germany, Korea, Republic of, Russian Federation, France, Israel, Hungary, Portugal, United Kingdom, Georgia, Ukraine
-
Janssen Research & Development, LLCCompletedPostmenopausal | Metastatic ER+ Her2- Breast CancerUnited States, France, Ukraine, United Kingdom, Belgium, Spain, Netherlands, Korea, Republic of, Russian Federation, Poland, Luxembourg, Ireland
-
Research and Practical Clinical Center for Diagnostics...RecruitingCOVID-19 | Fractures, Bone | Lung Cancer | Chest--Diseases | Brain Disease | Mammary Cancer | AI (Artificial Intelligence) | Abdomen Disease | X-Rays; LesionRussian Federation
-
YM BioSciencesCompletedMetastatic/Recurrent Breast CancerRussian Federation, Georgia, Ukraine
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast Cancer | Breast Neoplasms | HER2-positive Early Breast CancerUnited States, Italy, Spain, Poland, Taiwan, Thailand, Canada, Germany, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, China, Saudi Arabia, Russian Federation, Bulgaria
-
Mast Therapeutics, Inc.UnknownBreast CancerArgentina, Mexico, Peru, Russian Federation, Spain